Health ❯Healthcare ❯Regulatory Affairs ❯FDA

Drug Approval Process

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

FDA Proposes Removal of Ineffective Oral Phenylephrine from Cold Medicines

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

New Study Links Ozempic to Increased Risk of Suicidal Thoughts

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections